fitc conjugated anti cd34 (Bioss)
94
Structured Review
Bioss
fitc conjugated anti cd34
Fitc Conjugated Anti Cd34, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34+polyclonal+antibody%2C+fitc+conjugated/CD34+Polyclonal+Antibody%2C+FITC+Conjugated/pmc11791013-85-20-24
Average 94 stars, based on 7 article reviews
Fitc Conjugated Anti Cd34, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34+polyclonal+antibody%2C+fitc+conjugated/CD34+Polyclonal+Antibody%2C+FITC+Conjugated/pmc11791013-85-20-24
Average 94 stars, based on 7 article reviews
fitc conjugated anti cd34 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: Restoring tendon microenvironment in tendinopathy: Macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes Article Snippet: to 5 were utilized for subsequent experiments. For identification of TDSCs, cells at passage 3 were incubated with the following conjugated antibodies: FITC-conjugated anti-CD44 (1:50; bs-0521R-FITC; Cytometry:Article Title: Restoring tendon microenvironment in tendinopathy: Macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes Article Snippet: to 5 were utilized for subsequent experiments. For identification of TDSCs, cells at passage 3 were incubated with the following conjugated antibodies: FITC-conjugated anti-CD44 (1:50; bs-0521R-FITC; Flow Cytometry:Article Title: Restoring tendon microenvironment in tendinopathy: Macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes Article Snippet: to 5 were utilized for subsequent experiments. For identification of TDSCs, cells at passage 3 were incubated with the following conjugated antibodies: FITC-conjugated anti-CD44 (1:50; bs-0521R-FITC; |